Showing results (121-130 of 163) with videos related to
Sort By:
Pageof 17
Annals of Internal Medicine|September 1, 1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind studyA G Turpie, M Gent, R Côte, et al.Circulation|July 1, 1997
Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)W Klein, A Buchwald, S E Hillis, et al.Circulation|May 20, 1998
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]D B Mark, P A Cowper, S D Berkowitz, et al.BMJ (Clinical Research Ed.)|February 6, 1998
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort studyA Cogo, A W Lensing, M M Koopman, et al.British Medical Journal|August 22, 1970
Treatment of hypertension with clonidineA I MacDougall, G J Addis, N MacKay, et al.The New England Journal of Medicine|December 30, 1982
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosisR Hull, J Hirsh, R Jay, et al.Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.Lancet (London, England)|June 3, 1989
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeM Gent, J A Blakely, J D Easton, et al.The New England Journal of Medicine|September 9, 1999
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupM M Samama, A T Cohen, J Y Darmon, et al.Circulation|January 1, 1996
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fractureM Gent, J Hirsh, J S Ginsberg, et al.Pageof 17